Capivasertib-induced polymorphous lichenoid exanthem: Report of a novel AKT kinase inhibitor-related drug eruption by Raj P. Fadadu, MD, MS, Albert Lee, BA, Brian Hinds, MD, Charisse Orme, MD, PhD

Subjects: Get full text

Dupilumab for management of capecitabine-induced hand-foot syndrome by Ian Nykaza, BS, Rachel Sanford, MD, Allison Gordon, MD

Subjects: Get full text

Recognition and management of adverse cutaneous reactions in patients on enfortumab vedotin and pembrolizumab in the inpatient setting by Emma L. Myers, BA, Jessica Liu, BA, Sabrina M. Shearer, MD, Sarah A. Myers, MD, Michelle Schneider, MB, BCh, BAO, Christopher Hoimes, DO, Melodi Javid Whitley, MD, PhD

Subjects: Get full text

Tape Strip Profiling of Checkpoint Inhibitor–Associated Dermatitis Highlights Pan-T-Cell Activation: A Pilot Study by Camille M. Powers, Madeline Kim, Annie Chang, Benjamin D. Hu, Brandon R. Block, Austin J. Piontkowski, Jeremy Orloff, Jade N. Young, Yeriel D. Estrada, Digpal S. Gour, Emma Guttman-Yassky, Nicholas Gulati

Subjects: Get full text

A striking case of cutaneous adult T-cell leukemia/lymphoma mimicking subacute cutaneous lupus erythematosus by Daniel S. Alicea, MS, Suraj Muddasani, MD, Michael Occidental, MD, Bijal Amin, MD, Beth N. McLellan, MD, Benedict Wu, DO, PhD

Subjects: Get full text